JENNIFER SWEETMAN: Open Payments
NPI 1245875426 · ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 41 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $264 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $200 |
| Ferring Pharmaceuticals Inc. | 3 | $77 |
| Astellas Pharma US Inc | 3 | $70 |
| Dendreon Pharmaceuticals LLC | 3 | $65 |
| Antares Pharma, Inc. | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| 180 Medical, Inc. | 2 | $58 |
| COLOPLAST CORP | 2 | $52 |
| Caris MPI, Inc. | 1 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
Products named: GEMTESA, ADSTILADRIN, Xtandi, PROVENGE, XYOSTED, KEYTRUDA, GENTLECATH, Luja Coude.
Industry payments across MA — which companies pay providers there.
